Skip to content

To keep going please Log in.

Sign Up Sign In
or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Sign up.

Sign Up Sign In
or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

Sign Up Sign In
or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Sign up.

Sign Up Sign In
or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

XPH SPDR S&P Pharmaceuticals ETF
$41.04 -0.07% -0.03
Notify me if price changes either direction
Loading

Valuations metrics

Market capitalization 225.9M
Trailing pe 15.900973

ETF statistics

Avg 10 volume 32979
Avg 90 volume 42673

ETF price summary

Fifty two week low 35.22
Fifty two week high 48.76
Fifty two week change 3.07
Day 50 ma 40.2912
Day 200 ma 43.3922

Dividends and splits

Forward annual dividend rate 0.613276
Forward annual dividend yield 0.014943371986329
Trailing annual dividend rate 0.676737
Trailing annual dividend yield 0.016489692614601
Dividend frequency Quarterly
Ex dividend date 2025-03-24
Last split factor 2-for-1 split
Last split date 2015-09-11

Recent XPH News

Trade, Swap & Stake Crypto on Uphold

Buy, sell, and swap crypto. Stake crypto, earn rewards and securely manage 300+ assets—all in one trusted platform. Terms apply. Capital at risk.

Get Started

IMPORTANT NOTICE

Finbold is a news and information website. This Site may contain sponsored content, advertisements, and third-party materials, for which Finbold expressly disclaims any liability.

RISK WARNING: Cryptocurrencies are high-risk investments and you should not expect to be protected if something goes wrong. Don’t invest unless you’re prepared to lose all the money you invest. (Click here to learn more about cryptocurrency risks.)

By accessing this Site, you acknowledge that you understand these risks and that Finbold bears no responsibility for any losses, damages, or consequences resulting from your use of the Site or reliance on its content. Click here to learn more.